Mark G. Osterman

Mark G.
Osterman — Joined Discovery in June 2004 as Senior Vice President, Sales and Marketing.
Mr. Osterman brings with him over 16 years of industry experience with leading pharmaceutical companies.
Prior to Discovery, Mr. Osterman was at Johnson & Johnson where he served in a variety of positions including Vice President at Johnson & Johnson Development Corporation and Executive Director - Global Biologics Strategic Marketing Group at Centocor, Inc., where he oversaw and built marketing functions for the cardio-pulmonary, metabolism and infectious disease therapeutic areas.
While at Centocor, Mr. Osterman lead the commercial due diligence team in Johnson & Johnson’s acquisition of Scios Inc. Previously, Mr. Osterman was at GlaxoSmithKline, his most senior position being Director, Pulmonary Portfolio - Global Marketing Group where he was involved with the successful launch of several respiratory products including Serevent® for the COPD (Chronic Obstructive Pulmonary Disease) and pediatric indications.
Earlier in his career, Osterman was a product manager, respiratory medical liaison and sales representative.
Mr. Osterman has dual B.A.
degrees in Economics and Business Management from North Carolina State University.